<p>Association Between CYP17A1, CYB5A Polymorphisms and Efficacy of Abiraterone Acetate/Prednisone Treatment in Castration-Resistant Prostate Cancer Patients</p>-Reference-Cited by-同舟云学术

Association Between CYP17A1, CYB5A Polymorphisms and Efficacy of Abiraterone Acetate/Prednisone Treatment in Castration-Resistant Prostate Cancer Patients

Published:2020-06 Issue: Volume:Volume 13 Page:181-188
ISSN:1178-7066
Container-title:Pharmacogenomics and Personalized Medicine
language:en
Short-container-title:PGPM

Author:

Wu Xiang,Xu Qing-Jiang,Chen Ping-Zhou,Yu Chen-Bo,Ye Lie-Fu,Li Tao

Publisher

Informa UK Limited

Subject

Pharmacology,Molecular Medicine

Reference41 articles.

1. Biology of Progressive, Castration-Resistant Prostate Cancer: Directed Therapies Targeting the Androgen-Receptor Signaling Axis

2. Commentary on Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer

3. Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Cancer Stem Cell-related Gene by Single-cell and Machine Learning Predicts Immune Status, Chemotherapy Drug, and Prognosis in Lung Adenocarcinoma;Current Stem Cell Research & Therapy;2024-07

2. Cytochrome B5 type A alleviates HCC metastasis via regulating STOML2 related autophagy and promoting sensitivity to ruxolitinib;Cell Death & Disease;2022-07-18

3. Lack of association between CYB5A gene rs1790834 polymorphism and the response to leflunomide in women with rheumatoid arthritis;European Journal of Clinical Pharmacology;2021-06-23

4. Genetic Polymorphisms and Pharmacotherapy for Prostate Cancer;JMA Journal;2021